Companies:
50,394
Total Market Cap:
143955260025209.36
Global Rank
#11924
Country Rank
#3
Market Cap
731.85 M
Price
1.47
Change (%)
0.00%
Volume
68,915
Sopharma AD's latest marketcap:
731.85 M
As of 08/21/2025, Sopharma AD's market capitalization has reached $731.85 M. According to our data, Sopharma AD is the 11924th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 731.85 M |
| Revenue (ttm) | 1.35 B |
| Net Income (ttm) | 52.73 M |
| Shares Out | 499.09 M |
| EPS (ttm) | 0.1 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 07/10/2025 |
| Earnings Date | 07/30/2025 |
Market Cap Chart
Data Updated: 08/21/2025
Sopharma AD's yearly market capitalization.
Sopharma AD has seen its market value grow from 491.59 M BGN to 1.23 B BGN since 2014, representing a total increase of 149.75% and an annual compound growth rate (CAGR) of 8.98%.
| Date | Market Cap | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 08/21/2025 | 1.23 B | $731.85 M | 28.16% | 11924 |
| 12/27/2024 | 957.99 M | $508.39 M | 5.26% | 12878 |
| 12/29/2023 | 910.12 M | $513.74 M | 68.2% | 12797 |
| 12/29/2022 | 541.08 M | $294.8 M | -2.7% | 15664 |
| 12/30/2021 | 556.1 M | $321.75 M | 38.18% | 16046 |
| 12/30/2020 | 402.46 M | $252.31 M | -5.99% | 15481 |
| 12/30/2019 | 428.11 M | $245.69 M | -3.45% | 13771 |
| 12/28/2018 | 443.42 M | $259.37 M | -20.06% | 12613 |
| 12/29/2017 | 554.72 M | $339.87 M | 44.44% | 12313 |
| 12/30/2016 | 384.04 M | $206.79 M | 8.35% | 12674 |
Company Profile
About Sopharma AD
Sopharma AD is a leading pharmaceutical company specializing in the production, distribution, and export of medical products across Europe, Bulgaria, and international markets. Founded in 1933 and headquartered in Sofia, Bulgaria, the company offers a diverse portfolio of healthcare solutions.
Key Products & Services
- Pharmaceutical Products: Includes treatments such as Carsil (liver disease), Tempalgin (painkiller), Tabex (smoking cessation), and Tribestan (male reproductive health).
- Medical Devices: Supplies gauzes, compresses, dressings, and other essential healthcare materials.
- Food Supplements & Cosmetics: Offers herbal cosmetics, vitamins, and sanitary-hygiene products.
- Prescription & OTC Medicines: Provides both prescription drugs and over-the-counter medications, including veterinary products.
- Contract Manufacturing: Delivers packaging, product development, and manufacturing services.
- Distribution & Retail: Engages in wholesale and retail trade of pharmaceuticals, medical equipment, and cosmetics.
Additional Business Activities
Sopharma AD also operates in:
- Trading of radioactive materials for medicinal use.
- Production and trade of herbs and medicinal plants.
- Public opinion research and consulting services.
- Franchising, property rental, and online/offline retail.
Frequently Asked Questions
-
What is Sopharma AD's (BUL-SFA) current market cap?As of 08/21/2025, Sopharma AD (including the parent company, if applicable) has an estimated market capitalization of $731.85 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Sopharma AD (BUL-SFA) rank globally by market cap?Sopharma AD global market capitalization ranking is approximately 11924 as of 08/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.